Older and younger patients with advanced renal cell carcinoma (RCC) derive similar benefit from sorafenib, data suggest.

Vitespen (Oncophage), an experimental vaccine, does not prevent renal cell carcinoma (RCC) recurrence or improve survival, researchers reported in The Lancet (2008; published online ahead of print).

AGE IS AN independent prognostic factor in women, but not men, with renal cell carcinoma (RCC), according to researchers.

AGE IS AN independent prognostic factor in women, but not men, with renal cell carcinoma (RCC), according to researchers.

CHICAGO—Sunitinib (Sutent) remains a reference standard for the first-line treatment of metastatic renal cell carcinoma (RCC), with updated findings from a phase 3 trial confirming the superior efficacy of this agent over interferon-alfa, researchers reported here at the American Society of Clinical Oncology annual meeting.

CHICAGO—Everolimus, an experimental targeted therapy, significantly delays progression of metastatic kidney cancer in patients whose disease has worsened despite treatment, according to results of a phase III trial.

WASHINGTON, D.C.—Cryoablation is an appropriate option for patients with unresectable renal masses, but long-term follow-up studies are needed before this modality can be expanded to treatment of all potential surgical candidates, researchers say.

SAN DIEGO—Dutch researchers say that they have identified potential biomarkers which might help physicians monitor the effectiveness of bevacizumab in non-small-cell lung cancer (NSCLC) patients and in patients with advanced kidney cancer treated with sunitinib.

WASHINGTON, D.C.—A "halo sign" is a common delayed finding following radiofrequency ablation (RFA) of kidney tumors, according to researchers at the University of Toronto.

DIETARY INTAKE of acrylamide, a probable human carcinogen, may be associated with an increased risk of renal cell cancer, according to a report in the American Journal of Clinical Nutrition (2008;87:1428-1438).